NEW DELHI, INDIA, September 30, 2012 (Press-News.org) Wyzax Surrogacy Consultants (WSC) is a specialized surrogacy arm of Wyzax Corp., which is engaged in a vast range of healthcare activities like Pharmaceutical marketing, Biotechnological research and Medical Tourism.
WSC is The Only Healthcare Corporate in India which functions differently from the ART clinics because unlike the latter, we work on the US model, whereby, rather than carrying out IVF at our own centre, we offer the IPs the option of getting the IVF done at any of the world class ART clinics which are on our panel. We at WSC provides end to end surrogacy solutions under 1 roof, including country specific legal procedures, surrogate selection & maintenance, donor selection, gamete banking as well as exit visa formalities.
Moreover, as per the ART Bill 2010 ,ref ART Bill 2010 - Chapter V; Clause 26; Para (1)(2 ), an ART/IVF centre should not provide any direct surrogacy services to the IPs & should not engage itself in any direct commercial engagements with the latter. All this should be done through a specialised surrogacy agency/ ART bank. Thus WSC acts as the ART Bank. This not only reduces the chances of clinical compromise but also removes any conflict of commercial & clinical interests, thereby, providing transparency, accountability & professionalism to the entire process.
We at WSC are also different from other agencies because unlike the latter, we do not have tie up with 1 particular ART clinic, but we have all top notch ART clinics on our panel, thereby providing options to the IPs with regards to package options, costs & protocols adopted at different centres. Moreover, at all these centres, we offer multiple attempts to IPs for better success rates. In addition to this , we are only agency/ consultancy which houses the surrogates in our own surrogate homes for better monitoring, upkeep & emergency handling.
WSC has pioneered towards organising the Surrogacy sector in India & made it medically, legally, socially & ethically accountable through its Pioneering Surrogacy Protocols (PSPs), which include the following:
1 Creating Standardized Operating Procedures (SOPs) for screening, recruiting, monitoring, compensating & housing the surrogate mothers through a specialised Quartet Operating System.
2 Giving multiple options to IPs (Intended Parents) from amongst the top notch IVF centres across India.
3 Giving multiple options of Customized, Economical packages which include multiple IVF-ET attempts.
4 Providing comprehensive End to End Surrogacy Solutions - Surrogacy , IVF, Delivery, Legalities & Exit visas.
We are Experts at handling all challenges that might arise during the process of surrogacy. Our company's One & Only motto is to make the surrogacy journey pleasurable a]nd fruitful for YOU !
The 3 main features of WSC are:
1. Experience 2. Experience 3. Experience
Wyzax Surrogacy Consultants India
603, Vishwadeep Tower,
District Centre, Janakpuri
New Delhi-110058
India
Web: http://www.surrogacyindiadelhi.com, http://www.delhi-surrogacy.com
Email: info@surrogacyindiadelhi.com
Videos: http://www.youtube.com/SurrogacyIndiaDelhi
Facebook: http://www.facebook.com/SurrogacyIndiaDelhi
Twitter: http://twitter.com/ivfsurrogacy
Blog: http://ivfsurrogacyindia.blogspot.com/
Wyzax Surrogacy Consultant - Pioneers of Surrogacy in India.
Surrogacy India - Wyzax The Only Healthcare Corporate for Surrogacy in Delhi
WSC is The Only Healthcare Corporate in India which functions differently from the ART clinics because unlike the latter, we work on the US model, whereby, rather than carrying out IVF at our own centre.
2012-09-30
ELSE PRESS RELEASES FROM THIS DATE:
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer
2012-09-29
Vienna, Austria, 29 September 2012 – Treatment with the drug sorafenib as a third or fourth line therapy does not result in improved overall survival among patients with advanced non-small cell lung cancer (NSCLC), according to findings released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. However, a post-hoc biomarker analysis of the trial data that was also presented suggests that patients with EGFR-mutant tumors may benefit.
Sorafenib is an oral inhibitor of several tyrosine protein kinases, which can be active in cancers. At the ...
Studies show drug combinations effective for melanoma
2012-09-29
Vienna, Austria, 29 September 2012 –- Promising new data on drug combinations to treat metastatic melanoma are presented at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
The phase I and II trials focus on combining drugs to slow the development of resistance to drugs that inhibit BRAF, a gene that is mutated in about half of melanomas. Earlier trials with drugs that target BRAF generated excitement for their ability to quickly shrink melanoma tumors in suitable patients. But for many patients the benefits proved short-lived, as the cancer ...
Studies show advances in gastrointestinal cancer treatments
2012-09-29
VIENNA, Austria, 29 September 2012 –- New trial data showing improvements in the treatment of esophageal and gastrointestinal cancers were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Phase III, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy
The first phase III trial to address the need for second-line treatments in esophageal cancer shows that gefitinib improves important quality-of-life measures and extends progression-free survival, ...
Governments failing to address 'global pandemic of untreated cancer pain'
2012-09-29
Vienna, Austria, 29 September 2012 –- Governments around the world are leaving hundreds of millions of cancer patients to suffer needlessly because of their failure to ensure adequate access to pain-relieving drugs, an unprecedented new international survey reveals.
The new data, released to the public during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna, paints a shocking picture of unnecessary pain on a global scale, said Prof Nathan Cherny, lead author of the report from Shaare Zedek Medical Center, Jerusalem, Israel, Chair of the ESMO ...
Combination of targeted treatment drugs delays resistance in melanoma patients
2012-09-29
Combined treatment with two drugs targeting different points in the same growth-factor pathway delayed the development of treatment resistance in patients with BRAF-positive metastatic malignant melanoma. The results of a phase I/II study of treatment with the kinase inhibitors dabrafenib and trametinib will be published in the New England Journal of Medicine and are being released online to coincide with a presentation at the European Society for Medical Oncology meeting in Vienna.
"We investigated this combination because of research we and others have conducted ...
URI scientists: Marine plants can flee to avoid predators
2012-09-29
NARRAGANSETT, R.I. – September 28, 2012 – Scientists at the University of Rhode Island's Graduate School of Oceanography have made the first observation of a predator avoidance behavior by a species of phytoplankton, a microscopic marine plant. Susanne Menden-Deuer, associate professor of oceanography, and doctoral student Elizabeth Harvey made the unexpected observation while studying the interactions between phytoplankton and zooplankton.
Their discovery will be published in the September 28 issue of the journal PLOS ONE.
"It has been well observed that phytoplankton ...
An old insect pest reemerges in organic orchards
2012-09-29
The apple flea weevil, a sporadic insect pest in the early 1900s, has reemerged as a severe pest in organic apple orchards in Michigan, where outbreak population levels have been observed since 2008, and damage has resulted in up to 90% losses for apple growers.
According to the authors of "The Reemergence of an Old Pest, Orchestes pallicornis (Coleoptera: Curculionidae)," an open-access article appearing in the lastest issue of the Journal of Integrated Pest Management, the weevil can be managed by broad-spectrum insecticides used in conventional agriculture, but there ...
Researchers find multiple similarities between cancer cells and induced pluripotent stem cells
2012-09-29
(SACRAMENTO, Calif.) — UC Davis investigators have found new evidence that a promising type of stem cell now being considered for a variety of disease therapies is very similar to the type of cells that give rise to cancer. The findings suggest that although the cells -- known as induced pluripotent stem cells (iPSCs) -- show substantial promise as a source of replacement cells and tissues to treat injuries, disease and chronic conditions, scientists and physicians must move cautiously with any clinical use because iPSCs could also cause malignant cancer.
The article, ...
New method monitors semiconductor etching as it happens -- with light
2012-09-29
CHAMPAIGN, Ill. — University of Illinois researchers have a new low-cost method to carve delicate features onto semiconductor wafers using light – and watch as it happens.
"You can use light to image the topography and you can use light to sculpture the topography," said electrical and computer engineering professor Gabriel Popescu. "It could change the future of semiconductor etching."
Chip makers and semiconductor researchers need to very precisely control the dimensions of their devices. The dimensions of the components affect performance, speed, error rate and time ...
Tadpole shrimp a new pest of rice in the midsouthern United States
2012-09-29
Tadpole shrimp are pests of rice production systems in California and have recently been found impacting Missouri and Arkansas rice fields. The shrimp feed on rice seedlings and uproot them during foraging, and their foraging behavior causes water to become muddy, which reduces light penetration to submerged seedlings and delays the development of the rice plant.
In "Review of a New Pest of Rice, Tadpole Shrimp (Notostraca: Triopsidae), in the Midsouthern United States and a Winter Scouting Method of Rice Fields for Preplanting Detection," a new open-access article appearing ...
LAST 30 PRESS RELEASES:
New switch for programmed cell death identified
Orcas seen killing young great white sharks by flipping them upside-down
ETRI achieves feat of having its technology adopted as Brazil’s broadcasting standard
Agricultural practices play a decisive role in the preservation or degradation of protected areas
Longer distances to family physician has negative effect on access to health care
Caution advised with corporate virtual care partnerships
Keeping pediatrics afloat in a sea of funding cuts
Giant resistivity reduction in thin film a key step towards next-gen electronics for AI
First pregnancy with AI-guided sperm recovery method developed at Columbia
Global study reveals how bacteria shape the health of lakes and reservoirs
Biochar reimagined: Scientists unlock record-breaking strength in wood-derived carbon
Synthesis of seven quebracho indole alkaloids using "antenna ligands" in 7-10 steps, including three first-ever asymmetric syntheses
BioOne and Max Planck Society sign 3-year agreement to include subscribe to open pilot
How the arts and science can jointly protect nature
Student's unexpected rise as a researcher leads to critical new insights into HPV
Ominous false alarm in the kidney
MSK Research Highlights, October 31, 2025
Lisbon to host world’s largest conference on ecosystem restoration in 2027, led by researcher from the Faculty of Sciences, University of Lisbon
Electrocatalysis with dual functionality – an overview
Scripps Research awarded $6.9 million by NIH to crack the code of lasting HIV vaccine protection
New post-hoc analysis shows patients whose clinicians had access to GeneSight results for depression treatment are more likely to feel better sooner
First transplant in pigs of modified porcine kidneys with human renal organoids
Reinforcement learning and blockchain: new strategies to secure the Internet of Medical Things
Autograph: A higher-accuracy and faster framework for compute-intensive programs
Expansion microscopy helps chart the planktonic universe
Small bat hunts like lions – only better
As Medicaid work requirements loom, U-M study finds links between coverage, better health and higher employment
Manifestations of structural racism and inequities in cardiovascular health across US neighborhoods
Prescribing trends of glucagon-like peptide 1 receptor agonists for type 2 diabetes or obesity
Continuous glucose monitoring frequency and glycemic control in people with type 2 diabetes
[Press-News.org] Surrogacy India - Wyzax The Only Healthcare Corporate for Surrogacy in DelhiWSC is The Only Healthcare Corporate in India which functions differently from the ART clinics because unlike the latter, we work on the US model, whereby, rather than carrying out IVF at our own centre.